Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Surface Oncology Inc (SURF)

Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Surface Oncology Inc 50 HAMPSHIRE STREET 8TH FLOOR CAMBRIDGE MA 02139 USA

www.surfaceoncology.com P: 617-714-4096

Description:

Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 65,082
Enterprise Value, $K -59,738
Shares Outstanding, K 60,824
Annual Sales, $ 30,000 K
Annual Net Income, $ -63,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -28,190 K
EBIT, $ -89,380 K
EBITDA, $ -87,870 K
60-Month Beta 1.75
% of Insider Shareholders 12.00%
% of Institutional Shareholders 37.21%
Float, K 53,525
% Float 88.00%
Short Volume Ratio 0.17

Growth:

1-Year Return -18.94%
3-Year Return -83.79%
5-Year Return -89.91%
5-Year Revenue Growth 133.83%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.41 on 08/02/23
Next Earnings Date 11/01/23
Earnings Per Share ttm -1.48
EPS Growth vs. Prev Qtr -24.24%
EPS Growth vs. Prev Year 10.87%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SURF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -107.81%
Return-on-Assets % -65.58%
Profit Margin % -211.97%
Debt/Equity 0.00
Price/Sales 2.19
Price/Cash Flow N/A
Price/Book 1.32
Book Value/Share 0.81
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar